Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,735 | 1,084 | 75.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,868 | 22 | 22.4% |
| Consulting Fee | $425.00 | 1 | 1.6% |
| Education | $68.78 | 10 | 0.3% |
| Gift | $59.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tandem Diabetes Care, Inc. | $6,526 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,772 | 101 | $0 (2024) |
| Novo Nordisk Inc | $2,653 | 172 | $0 (2024) |
| Lilly USA, LLC | $2,383 | 148 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,292 | 70 | $0 (2024) |
| ABBVIE INC. | $941.71 | 63 | $0 (2024) |
| Dexcom, Inc. | $777.27 | 49 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $774.00 | 44 | $0 (2024) |
| Amgen Inc. | $766.83 | 41 | $0 (2024) |
| Insulet Corporation | $696.13 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,319 | 112 | Lilly USA, LLC ($362.86) |
| 2023 | $2,486 | 142 | Lilly USA, LLC ($355.89) |
| 2022 | $2,387 | 135 | Lilly USA, LLC ($341.03) |
| 2021 | $1,753 | 99 | Lilly USA, LLC ($255.85) |
| 2020 | $3,074 | 90 | Tandem Diabetes Care, Inc. ($1,489) |
| 2019 | $3,182 | 148 | Tandem Diabetes Care, Inc. ($918.58) |
| 2018 | $6,453 | 190 | Tandem Diabetes Care, Inc. ($3,480) |
| 2017 | $4,502 | 202 | AstraZeneca Pharmaceuticals LP ($728.11) |
All Payment Transactions
1,118 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $16.97 | General |
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.73 | General |
| 12/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Endocrinology | ||||||
| 11/08/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: Automated insulin delivery system | ||||||
| 11/07/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/31/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $37.84 | General |
| Category: Insulin Pump | ||||||
| 10/24/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Endocrinology | ||||||
| 10/07/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/02/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,233 | 2,503 | $296,156 | $114,191 |
| 2022 | 12 | 1,357 | 2,660 | $324,291 | $125,964 |
| 2021 | 9 | 1,134 | 2,261 | $285,511 | $114,418 |
| 2020 | 8 | 1,117 | 2,044 | $289,667 | $98,231 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 359 | 858 | $195,624 | $78,358 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 214 | $33,170 | $12,421 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $29,465 | $10,159 | 34.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 262 | 562 | $14,050 | $5,294 | 37.7% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 292 | 665 | $7,980 | $2,538 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $5,236 | $2,420 | 46.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 34 | 51 | $4,794 | $1,369 | 28.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,893 | $1,257 | 32.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 36 | $1,944 | $376.33 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 323 | 797 | $181,716 | $76,583 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 326 | $50,530 | $20,028 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 81 | 81 | $28,755 | $10,455 | 36.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 248 | 536 | $13,400 | $5,112 | 38.1% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 34 | 34 | $11,832 | $3,511 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $9,160 | $2,819 | 30.8% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 289 | 677 | $8,124 | $2,616 | 32.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 31 | 31 | $10,788 | $2,042 | 18.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 36 | 56 | $5,264 | $1,521 | 28.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 26 | 54 | $2,916 | $563.28 | 19.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $756.00 | $419.44 | 55.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 14 | 14 | $1,050 | $295.26 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 346 | 836 | $190,608 | $80,461 | 42.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 135 | 190 | $29,450 | $11,699 | 39.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 78 | 78 | $27,690 | $9,643 | 34.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 232 | 471 | $11,775 | $4,488 | 38.1% |
About Dr. Sonia Eapen, M.D
Dr. Sonia Eapen, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Pearland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427242171.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sonia Eapen, M.D has received a total of $26,156 in payments from pharmaceutical and medical device companies, with $2,319 received in 2024. These payments were reported across 1,118 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($19,735).
As a Medicare-enrolled provider, Eapen has provided services to 4,841 Medicare beneficiaries, totaling 9,468 services with total Medicare billing of $452,804. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Pearland, TX
- Active Since 09/05/2007
- Last Updated 04/18/2016
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427242171
Products in Payments
- t-slim insulin pump (Device) $4,898
- FARXIGA (Drug) $2,547
- t:slim X2 insulin pump (Device) $1,489
- Ozempic (Drug) $1,309
- JARDIANCE (Drug) $1,029
- Omnipod (Device) $696.13
- BAQSIMI (Drug) $536.42
- HUMULIN (Drug) $513.40
- OneTouch (Device) $510.73
- AFREZZA (Drug) $464.12
- Victoza (Drug) $408.57
- V-GO (Device) $399.71
- SOLIQUA (Drug) $392.03
- SYNTHROID (Drug) $370.72
- UNITHROID (Drug) $354.59
- JANUVIA (Drug) $353.11
- TRULICITY (Drug) $321.49
- Synthroid (Drug) $308.36
- SOLIQUA 100/33 (Biological) $306.82
- CeQur Simplicity (Device) $305.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.